VVUS

VIVUS, Inc. Press Releases

$2.925
*  
0.055
1.85%
Get VVUS Alerts
*Delayed - data as of Mar. 5, 2015 14:12 ET  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VVUS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
VIVUS Reports Fourth Quarter and Year-End 2014 Financial Results
2/24/2015 4:00:00 PM - Market Wire


VIVUS to Present at Upcoming Investor Conference
2/20/2015 7:00:00 AM - Market Wire


VIVUS Announces Date of Fourth Quarter and Year End 2014 Update and Financial Results Conference Call
2/19/2015 7:00:00 AM - GlobeNewswire


VIVUS Announces European Approval of SPEDRA Label Amendment; SPEDRA Now First and Only Oral Erectile Dysfunction Treatment Approved in Europe to Be Taken Approximately 15 Minutes Before Sexual Activity
1/29/2015 7:00:00 AM - Market Wire
▲10.80 % Price Change since this news event. The Volume Ratio is 0.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Vivus Inc. Faces Strong Growth in 2015, Narrowing Loss Estimates and Large Stakes of Vivus Being Purchased by North Tide Capital: Analyst Report Issued By BrokerBank Securities, Inc.
1/15/2015 7:00:00 AM - PR Newswire
▼-2.50 % Price Change since this news event. The Volume Ratio is 1.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


VIVUS to Present at Upcoming Investor Conference
1/9/2015 7:00:00 AM - Market Wire
▼-7.44 % Price Change since this news event. The Volume Ratio is 0.55.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


VIVUS Announces Favorable Formulary Positioning for Qsymia
12/15/2014 7:00:00 AM - Market Wire
▼-2.50 % Price Change since this news event. The Volume Ratio is 1.52.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day